Abstract
ABSTRACTThere is growing evidence that showsClostridium(Clostridioides)difficileis a pathogen of One Health importance with a complex dissemination pathway involving animals, humans and the environment. Thus, environmental discharge and agricultural recycling of human and animal waste have been suspected as factors behind the dissemination ofC. difficilein the community. Here, the presence ofC. difficilein 12 wastewater treatment plants (WWTPs) in Western Australia was investigated. Overall,C. difficilewas found in 90.5% (114/126) of raw sewage influent, 48.1% (50/104) of treated effluent, 40% (2/5) of reclaimed irrigation water, 100% (38/38) of untreated biosolids, 95.2% (20/21) of anaerobically digested biosolids and 72.7% (8/11) of lime-amended biosolids. Over half the isolates (55.3%, 157/284) were toxigenic and 97C. difficileribotypes (RTs) were identified with RT014/020 the most common (14.8%, 42/284). ThirteenC. difficileisolates with the toxin profile A+B+CDT+ were found, including the hypervirulent RT078 strain. Resistance to the antimicrobials fidaxomicin, vancomycin, metronidazole, rifaximin, amoxicillin/clavulanate, meropenem and moxifloxacin was uncommon, however, resistance to clindamycin, erythromycin and tetracycline was relatively frequent at 56.7% (161/284), 14.4% (41/284) and 13.7% (39/284), respectively. This study revealed that toxigenicC. difficilewas commonly encountered in WWTPs and being released into the environment. This raises concern about the possible spill-over ofC. difficileinto animal and/or human populations via land receiving the treated waste. In Western Australia, stringent measures are in place to mitigate the health and environmental risk of recycling human waste, however, further studies are needed to elucidate the public health significance ofC. difficilesurviving the treatment processes at WWTPs.IMPORTANCEClostridium difficileinfection (CDI) is a leading cause of antimicrobial-associated diarrhoea in healthcare facilities. Extended hospital stays and recurrences increase the cost of treatment, and morbidity and mortality. Community-associated CDI (CA-CDI) cases, with no history of antimicrobial use or exposure to healthcare settings, are increasing. The isolation of clinically importantC. difficilestrains from animals, rivers, soil, meat, vegetables, compost, treated wastewater and biosolids has been reported. The objective of this study was to characteriseC. difficilein wastewater treatment plants (WWTPs) in Australia. We found thatC. difficilecan persist through the treatment processes of WWTPs and toxigenicC. difficilewas being released into the environment becoming a potential source/reservoir for CA-CDI.
Publisher
Cold Spring Harbor Laboratory
Reference56 articles.
1. Clostridium difficile infection: new developments in epidemiology and pathogenesis
2. Centers for Disease Control and Prevention. 2013. Antibiotic resistance threats in the United States, 2013. Department of Health and Human Services, Atlanta, GA.
3. Centers for Disease Control and Prevention. 2019. Antibiotic resistance threats in the United States 2019. Department of Health and Human Services, Atlanta, GA.
4. Burden ofClostridium difficileInfection in the United States
5. Increasing incidence of Clostridium difficile infection, Australia, 2011–2012